Dr. Reddy’s shares in focus after $50.5 million acquisition marking anti-vertigo foray

September 11, 2025
Uncategorized

The acquisition strengthens Dr. Reddy’s Central Nervous System (CNS) Portfolio in India and Emerging Markets through its foray into the antivertigo segment.

Dr. Reddy’s shares in focus after $50.5 million acquisition marking anti-vertigo foray

Leave a ReplyCancel Reply

Trump adds a 10% tariff on all imports three days from now

S&P 500 rises to the day’s high as Trump decides to overrule SC

NTPC Green starts 158 MW Kadapa solar operations; group capacity rises to 9,151 MW

LIC raises stake in Cipla to 9.1% after buying over 2% in three months

GIFT Nifty soars as US Supreme Court rules against Trump tariffs